Kraig Biocraft Laboratories to Hold Shareholder Conference Call to Discuss Spider Silk Commercialization and Intellectual Proper
October 01 2010 - 8:05AM
Marketwired
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB) announces today
that Kim Thompson cordially invites all current, new and
prospective shareholders to participate in the Company's conference
call to be held on Friday, October 8, 2010 at 4:30 p.m. EDT.
Thompson, the Company's CEO and Founder, will review the recent
development of recombinant spider silk, the Company's intellectual
property and commercialization rights to this powerful technology,
as well as what is in the pipeline for near term research and
development payoff, followed by a question and answer period.
The conference call phone number and other details will be
announced in a follow-up company release early next week.
Shareholders are invited to submit questions to benh@ttfsco.com
prior to the event.
For more information on Kraig Biocraft Laboratories please visit
the Company's web site: http://www.KraigLabs.com.
Statements in this press release about the company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops," "researching," "research,"
"potential," "could" or other words or phrases of similar import.
Similarly, statements in this release that describe the Company's
business strategy, outlook, objectives, plans, intentions or goals
should all be considered forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Management cautions that
its ability to further its research, and create commercially-viable
products may be affected by the competitive environment, the
Company's financial condition and its ability to raise sufficient
capital to meet the financial obligations of its business plan and
to fund its continuing operations.
Contact: Ben Hansel (720) 288-8495 Email Contact
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024